Following are articles published by the National Institute of Justice
Meeting the Evolving Challenges of Fentanyl and Other Emerging Drugs of Abuse: Innovative Strategies for Improving Analysis
NIJ-supported research offers new workflow for complicated drug analysis, improves upon traditional workflow.
Challenges in Identifying Novel Psychoactive Substances and a Stronger Path Forward
The importance of non-targeted testing to keep pace with a rapidly evolving synthetic opioid market.
How Good Are the Data? Novel Metric Assesses Probability That an Unknown Drug Sample Matches a Known Sample
NIJ-funded researchers developed a novel metric to assess probability that an unknown sample of a drug matches a library sample, with profound implications for standardization of mass spectrometry results.
Efficient Casework Policy To Address Emerging Challenges in Seized Drugs
The substances tested in cases involving seized drugs are always evolving. By establishing policies on the most critical samples to test and maintaining ongoing communication with stakeholders, laboratories can more efficiently manage a backlog.